Squires, Kathleen E <br/><br/>
Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study.  [electronic resource] 

 -  AIDS research and human retroviruses  Jun 2013 
 - 859-70 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1931-8405 
<br/><br/><label>Standard No.: </label>10.1089/AID.2012.0292  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-HIV Agents--administration & dosage<br/>Drug Resistance, Viral<br/>Drug Therapy, Combination<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Integrase Inhibitors--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Pyrrolidinones--administration & dosage<br/>Racial Groups<br/>Raltegravir Potassium<br/>Sex Factors<br/>Treatment Outcome<br/>Viral Load--drug effects<br/>Young Adult